Caraglia M - Search Results

1

Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro.

Correale P, Cusi MG, Del Vecchio MT, Aquino A, Prete SP, Tsang KY, Micheli L, Nencini C, La Placa M, Montagnani F, Terrosi C, Caraglia M, Formica V, Giorgi G, Bonmassar E, Francini G. Correale P, et al. Among authors: caraglia m. J Immunol. 2005 Jul 15;175(2):820-8. doi: 10.4049/jimmunol.175.2.820. J Immunol. 2005. PMID: 16002679 Free article.

2

Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity.

Correale P, Procopio A, Celio L, Caraglia M, Genua G, Coppola V, Pepe S, Normanno N, Vecchio I, Palmieri G, et al. Correale P, et al. Among authors: caraglia m. Cancer Immunol Immunother. 1992;34(4):272-8. doi: 10.1007/BF01741796. Cancer Immunol Immunother. 1992. PMID: 1371427 Free PMC article.

3

5-Aza-2'-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells.

Caraglia M, Pinto A, Correale P, Zagonel V, Genua G, Leardi A, Pepe S, Bianco AR, Tagliaferri P. Caraglia M, et al. Ann Oncol. 1994 Mar;5(3):269-76. doi: 10.1093/oxfordjournals.annonc.a058806. Ann Oncol. 1994. PMID: 7514437 Free article.

4

Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.

Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR. Caraglia M, et al. Cancer Immunol Immunother. 1993 Aug;37(3):150-6. doi: 10.1007/BF01525428. Cancer Immunol Immunother. 1993. PMID: 8392910 Free PMC article.

5

Extracellular adenosine 5' triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation.

Correale P, Tagliaferri P, Guarrasi R, Caraglia M, Giuliano M, Marinetti MR, Bianco AR, Procopio A. Correale P, et al. Among authors: caraglia m. Immunol Lett. 1997 Feb;55(2):69-78. doi: 10.1016/s0165-2478(96)02687-9. Immunol Lett. 1997. PMID: 9143936

6

A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.

Correale P, Messinese S, Caraglia M, Marsili S, Piccolomini A, Petrioli R, Ceciarini F, Micheli L, Nencini C, Neri A, Vuolo G, Guarnieri A, Abbruzzese A, Prete SD, Giorgi G, Francini G. Correale P, et al. Among authors: caraglia m. Br J Cancer. 2004 May 4;90(9):1710-4. doi: 10.1038/sj.bjc.6601783. Br J Cancer. 2004. PMID: 15150625 Free PMC article. Clinical Trial.

7

Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.

Correale P, Fulfaro F, Marsili S, Cicero G, Bajardi E, Intrivici C, Vuolo G, Carli AF, Caraglia M, Del Prete S, Greco E, Gebbia N, Francini G. Correale P, et al. Among authors: caraglia m. Cancer Chemother Pharmacol. 2005 Dec;56(6):563-8. doi: 10.1007/s00280-005-1024-1. Epub 2005 Jul 23. Cancer Chemother Pharmacol. 2005. PMID: 16041610 Clinical Trial.

8

Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation.

Caraglia M, Marra M, Budillon A, Meo G, Ricciardiello F, Bismuto E, Brachelente G, Francini G, Giordano A, Correale P, Abbruzzese A. Caraglia M, et al. Cancer Biol Ther. 2005 Oct;4(10):1159-67. doi: 10.4161/cbt.4.10.2206. Epub 2005 Oct 23. Cancer Biol Ther. 2005. PMID: 16294035 Free article.

9

Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine.

Correale P, Tindara Miano S, Remondo C, Migali C, Rotundo MS, Macrì P, Tagliaferri P, Caraglia M, Gotti G, Francini G. Correale P, et al. Among authors: caraglia m. Cancer Biol Ther. 2009 Mar 15;8(6):497-502. doi: 10.4161/cbt.8.6.7593. Epub 2009 Mar 15. Cancer Biol Ther. 2009. PMID: 19242101 Free article. Clinical Trial.

10

Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC).

Correale P, Marra M, Remondo C, Migali C, Misso G, Arcuri FP, Del Vecchio MT, Carducci A, Loiacono L, Tassone P, Abbruzzese A, Tagliaferri P, Caraglia M. Correale P, et al. Among authors: caraglia m. Eur J Cancer. 2010 Jun;46(9):1703-11. doi: 10.1016/j.ejca.2010.03.005. Eur J Cancer. 2010. PMID: 20399639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

541 results

Search Page

Filters